Select Language

Swedish innovation recognised in the UK- offsets the need for reflux medication and surgery

IQoro is a neuromuscular treatment and product for reflux and swallowing difficulties, which can offset the need for medication and surgery according to National Health Service innovation organisations in the UK. The Swedish innovation IQoro has been awarded the prestigious “Product of the Year” award at the Bionow Awards.

The Bionow Awards is one of the highlights of the year in Life Science and celebrates significant achievements within the industry.

The award recognizes the high quality and innovative solution that IQoro offers to a specific problem, namely treating the neuromuscular cause of reflux, heartburn, and swallowing difficulties without medication or surgery.

IQoro has received this recognition for its innovative and high-quality product that is already helping thousands of people regain their quality of life.

IQoro - the winner of the BioNow Product of the Year Award 2024
IQoro is awarded Product of the year at Bionow Awards

“The winning product is effective, easy to scale and can offset the need for surgery and medication so is therefore very impactful”

The jury’s rationale, NHS innovation organisation, Bionow Awards.

Great success despite a tough global economy

MYoroface, the healthtech company behind IQoro, has shown strong growth of 33 percent in a tough global economy in 2023. The German market grew by 244 percent and IQoro has exceeded 100,000 active users successfully utilising the treatment in Europe.

Used in the health care in the UK and the Nordic countries

IQoro is used in 100 National Health Service hospitals in the UK, and also in hospitals in Sweden, Denmark, and Norway. Since 2022, IQoro is available for prescription in all four countries in the UK. Individuals can also learn more about their symptoms and purchase IQoro at

I feel extremely honoured that IQoro has been named “Product of the Year” at the Bionow Awards. It is a quality stamp and recognition that we offer a new treatment opportunity for people with reflux, without medication or surgery, which is also available within UK healthcare on prescription since 2022.

Ylvali Gerling, CEO, MYoroface.

The National Health Service innovation organisations in the jury

The sponsors and jury for “Product of the Year” were three Academic Health Science Networks (AHSN): Health Innovation North West Coast, Health Innovation Manchester, and Health Innovation Yorkshire & Humber.

Established by the NHS

The AHSN´s were established by the NHS to promote innovations and act as a cohesive force between healthcare providers, commissioners, academia, and industry to meet the needs of the population and address healthcare challenges.

Bionow is a British non-profit collaboration organisation for biomedical and life science development.

For more information, please contact:

Linn Hägg, Co-founder, Communications Manager
Email: linn(a)
Phone: +46 70 344 89 55